In the model yeast Saccharomyces cerevisiae, RAD53 mutants are more sensitive than the wild type to DNA damage and fail to slow cell cycle progression (10); in humans, mutations in CHK2 are associated with increased breast cancer risk (11). The gene discussed is CHEK2; the disease is breast cancer.